Survival Outcomes and Predictive Biomarkers in Patients With HER2-Positive Breast Cancer Receiving Neoadjuvant Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Survival outcomes, digital TILs and on-treatment PET/CT during neoadjuvant therapy for HER2-positive breast cancer: results from the randomized PREDIX HER2 trial
Clin. Cancer Res 2022 Nov 30;[EPub Ahead of Print], A Matikas, H Johansson, P Grybäck, J Bjöhle, B Acs, C Boyaci, T Lekberg, H Fredholm, E Elinder, S Margolin, E Isaksson-Friman, A Bosch, H Lindman, J Arda, A Andersson, S Agartz, M Hellström, I Zerdes, J Hartman, J Bergh, T Hatschek, T FoukakisFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.